LatentSpace Therapeutics
Latent Space Therapeutics uses an AI-driven platform to create cancer therapies with superior safety and efficacy. The PULSAR platform analyzes extensive pharmacological data to identify patterns in drug efficacy and safety, enabling rapid generation of novel chemical entities with large therapeutic windows and integrating in-silico testing for retrosynthesis, toxicity, and efficacy. This is a B2B drug discovery platform serving pharmaceutical companies and research institutions and integrates core AI-driven drug design technologies. The company aims to accelerate development timelines and reduce costs while expanding access to effective cancer treatments.
LatentSpace Therapeutics
Latent Space Therapeutics uses an AI-driven platform to create cancer therapies with superior safety and efficacy. The PULSAR platform analyzes extensive pharmacological data to identify patterns in drug efficacy and safety, enabling rapid generation of novel chemical entities with large therapeutic windows and integrating in-silico testing for retrosynthesis, toxicity, and efficacy. This is a B2B drug discovery platform serving pharmaceutical companies and research institutions and integrates core AI-driven drug design technologies. The company aims to accelerate development timelines and reduce costs while expanding access to effective cancer treatments.